Department of Clinical Psychology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Department of Biostatistics and Epidemiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
BMC Psychol. 2024 Oct 2;12(1):526. doi: 10.1186/s40359-024-01735-4.
This clinical trial aims to assess the effectiveness of internet-based Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A) during the COVID-19 pandemic in reducing stress, anxiety, and depression, and psychological flexibility. 40 adolescents with subclinical features of emotional disorder randomly divided into two groups of intervention and control. The participants first completed DASS-21 and AAQ-2 questionnare online. Then, the intervention group received 12 sessions of UP-A through video calls on WhatsApp, 2 days per week each for 45 min. UP-A is an emotion-focused, cognitive-behavioral therapy consisting of 5 core modules or components that target temperamental characteristics, particularly neuroticism and resulting emotion dysregulation. Eventually the stress, anxiety, and depression levels decreased in intervention group and their psychological flexibility increased immediately and 3 months after the intervention. Clinical trial registration This study was registered by Iranian Registry of Clinical Trials (Prospective, ID: IRCT20210428051113N1, Registration date: 14/06/2021; https://en.irct.ir/trial/55900 ).
本临床试验旨在评估基于互联网的跨诊断情绪障碍统一治疗方案(UP-A)在 COVID-19 大流行期间对减少压力、焦虑和抑郁以及心理灵活性的有效性。40 名有情绪障碍亚临床特征的青少年被随机分为干预组和对照组两组。参与者首先在线完成 DASS-21 和 AAQ-2 问卷。然后,干预组通过 WhatsApp 视频通话接受 12 次 UP-A,每周 2 天,每次 45 分钟。UP-A 是一种以情绪为中心的认知行为疗法,包括 5 个核心模块或组件,针对气质特征,特别是神经质和由此导致的情绪失调。最终,干预组的压力、焦虑和抑郁水平下降,心理灵活性在干预后立即和 3 个月后增加。临床试验注册 本研究由伊朗临床试验注册中心(前瞻性,ID:IRCT20210428051113N1,注册日期:2021 年 6 月 14 日;https://en.irct.ir/trial/55900)注册。